Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data.

Pharmaceuticals (Basel) · 2024 · PMC10974491 · PMID 38543128

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost significantno p-value reported

Other ADRs of Interest An almost significant ROR comparing dari to RG1 was observed for the HLGT “allergic conditions”.

also in 1,004 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.